547 related articles for article (PubMed ID: 30459204)
1. Type 3 innate lymphoid cell: a new player in liver fibrosis progression.
Wang S; Li J; Wu S; Cheng L; Shen Y; Ma W; She W; Yang C; Wang J; Jiang W
Clin Sci (Lond); 2018 Dec; 132(24):2565-2582. PubMed ID: 30459204
[TBL] [Abstract][Full Text] [Related]
2. Interleukin-17 signaling in inflammatory, Kupffer cells, and hepatic stellate cells exacerbates liver fibrosis in mice.
Meng F; Wang K; Aoyama T; Grivennikov SI; Paik Y; Scholten D; Cong M; Iwaisako K; Liu X; Zhang M; Österreicher CH; Stickel F; Ley K; Brenner DA; Kisseleva T
Gastroenterology; 2012 Sep; 143(3):765-776.e3. PubMed ID: 22687286
[TBL] [Abstract][Full Text] [Related]
3. IL-17A plays a critical role in the pathogenesis of liver fibrosis through hepatic stellate cell activation.
Tan Z; Qian X; Jiang R; Liu Q; Wang Y; Chen C; Wang X; Ryffel B; Sun B
J Immunol; 2013 Aug; 191(4):1835-44. PubMed ID: 23842754
[TBL] [Abstract][Full Text] [Related]
4. Interleukin-22 ameliorates liver fibrogenesis by attenuating hepatic stellate cell activation and downregulating the levels of inflammatory cytokines.
Lu DH; Guo XY; Qin SY; Luo W; Huang XL; Chen M; Wang JX; Ma SJ; Yang XW; Jiang HX
World J Gastroenterol; 2015 Feb; 21(5):1531-45. PubMed ID: 25663772
[TBL] [Abstract][Full Text] [Related]
5. Antagonism of Interleukin-17A ameliorates experimental hepatic fibrosis by restoring the IL-10/STAT3-suppressed autophagy in hepatocytes.
Zhang XW; Mi S; Li Z; Zhou JC; Xie J; Hua F; Li K; Cui B; Lv XX; Yu JJ; Hu ZW
Oncotarget; 2017 Feb; 8(6):9922-9934. PubMed ID: 28039485
[TBL] [Abstract][Full Text] [Related]
6. Impaired CD4⁺ T cell stimulation of NK cell anti-fibrotic activity may contribute to accelerated liver fibrosis progression in HIV/HCV patients.
Glässner A; Eisenhardt M; Kokordelis P; Krämer B; Wolter F; Nischalke HD; Boesecke C; Sauerbruch T; Rockstroh JK; Spengler U; Nattermann J
J Hepatol; 2013 Sep; 59(3):427-33. PubMed ID: 23665286
[TBL] [Abstract][Full Text] [Related]
7. Fibromodulin, an oxidative stress-sensitive proteoglycan, regulates the fibrogenic response to liver injury in mice.
Mormone E; Lu Y; Ge X; Fiel MI; Nieto N
Gastroenterology; 2012 Mar; 142(3):612-621.e5. PubMed ID: 22138190
[TBL] [Abstract][Full Text] [Related]
8. Activated hepatic stellate cells impair NK cell anti-fibrosis capacity through a TGF-β-dependent emperipolesis in HBV cirrhotic patients.
Shi J; Zhao J; Zhang X; Cheng Y; Hu J; Li Y; Zhao X; Shang Q; Sun Y; Tu B; Shi L; Gao B; Wang FS; Zhang Z
Sci Rep; 2017 Mar; 7():44544. PubMed ID: 28291251
[TBL] [Abstract][Full Text] [Related]
9. Up-regulation of interleukin-22 mediates liver fibrosis via activating hepatic stellate cells in patients with hepatitis C.
Wu LY; Liu S; Liu Y; Guo C; Li H; Li W; Jin X; Zhang K; Zhao P; Wei L; Zhao J
Clin Immunol; 2015 May; 158(1):77-87. PubMed ID: 25771172
[TBL] [Abstract][Full Text] [Related]
10. Hyperactivated peripheral invariant natural killer T cells correlate with the progression of HBV-relative liver cirrhosis.
Wei X; Qian J; Yao W; Chen L; Guan H; Chen Y; Xie Y; Lu H; Zhang Z; Shi L; Lin X
Scand J Immunol; 2019 Aug; 90(2):e12775. PubMed ID: 31069827
[TBL] [Abstract][Full Text] [Related]
11. Type 3 cytokines IL-17A and IL-22 drive TGF-β-dependent liver fibrosis.
Fabre T; Molina MF; Soucy G; Goulet JP; Willems B; Villeneuve JP; Bilodeau M; Shoukry NH
Sci Immunol; 2018 Oct; 3(28):. PubMed ID: 30366940
[TBL] [Abstract][Full Text] [Related]
12. Adipose tissue-derived stem cells prevent fibrosis in murine steatohepatitis by suppressing IL-17-mediated inflammation.
Yamato M; Sakai Y; Mochida H; Kawaguchi K; Takamura M; Usui S; Seki A; Mizukoshi E; Yamashita T; Yamashita T; Ishida K; Nasti A; Tuyen HTB; Komura T; Yoshida K; Wada T; Honda M; Kaneko S
J Gastroenterol Hepatol; 2019 Aug; 34(8):1432-1440. PubMed ID: 30828861
[TBL] [Abstract][Full Text] [Related]
13. Amelioration of hepatic fibrosis by NK cell activation.
Muhanna N; Abu Tair L; Doron S; Amer J; Azzeh M; Mahamid M; Friedman S; Safadi R
Gut; 2011 Jan; 60(1):90-8. PubMed ID: 20660699
[TBL] [Abstract][Full Text] [Related]
14. Exosome-mediated activation of toll-like receptor 3 in stellate cells stimulates interleukin-17 production by γδ T cells in liver fibrosis.
Seo W; Eun HS; Kim SY; Yi HS; Lee YS; Park SH; Jang MJ; Jo E; Kim SC; Han YM; Park KG; Jeong WI
Hepatology; 2016 Aug; 64(2):616-31. PubMed ID: 27178735
[TBL] [Abstract][Full Text] [Related]
15. Diverse roles of invariant natural killer T cells in liver injury and fibrosis induced by carbon tetrachloride.
Park O; Jeong WI; Wang L; Wang H; Lian ZX; Gershwin ME; Gao B
Hepatology; 2009 May; 49(5):1683-94. PubMed ID: 19205035
[TBL] [Abstract][Full Text] [Related]
16. Pathological Roles of Interleukin-22 in the Development of Recurrent Hepatitis C after Liver Transplantation.
Gao Y; Ren H; Meng F; Li J; Cheung E; Li H; Zhao J; Liu H; Liu Z; Zhang M
PLoS One; 2016; 11(4):e0154419. PubMed ID: 27123854
[TBL] [Abstract][Full Text] [Related]
17. Yu Gan Long reduces rat liver fibrosis by blocking TGF-β1/Smad pathway and modulating the immunity.
Xia Y; Yu B; Ma C; Tu Y; Zhai L; Yang Y; Liu D; Liu Y; Wu H; Dan H; You P
Biomed Pharmacother; 2018 Oct; 106():1332-1338. PubMed ID: 30119204
[TBL] [Abstract][Full Text] [Related]
18. The direct profibrotic and indirect immune antifibrotic balance of blocking the cannabinoid 2 receptor.
Avraham Y; Amer J; Doron S; Abu-Tair L; Mahamid M; Khatib A; Berry EM; Safadi R
Am J Physiol Gastrointest Liver Physiol; 2012 Jun; 302(12):G1364-72. PubMed ID: 22517772
[TBL] [Abstract][Full Text] [Related]
19. Interleukin-33-dependent innate lymphoid cells mediate hepatic fibrosis.
McHedlidze T; Waldner M; Zopf S; Walker J; Rankin AL; Schuchmann M; Voehringer D; McKenzie AN; Neurath MF; Pflanz S; Wirtz S
Immunity; 2013 Aug; 39(2):357-71. PubMed ID: 23954132
[TBL] [Abstract][Full Text] [Related]
20. STAT1 Represses Cytokine-Producing Group 2 and Group 3 Innate Lymphoid Cells during Viral Infection.
Stier MT; Goleniewska K; Cephus JY; Newcomb DC; Sherrill TP; Boyd KL; Bloodworth MH; Moore ML; Chen K; Kolls JK; Peebles RS
J Immunol; 2017 Jul; 199(2):510-519. PubMed ID: 28576981
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
